Efficacy and safety of switching to ixekizumab in secukinumab nonresponders with plaque psoriasis: A multicenter retrospective study of interleukin 17A antagonist therapies

被引：43

作者：

Georgakopoulos, Jorge R. ^{[1
]}

Phung, Michelle ^{[2
]}

Ighani, Arvin ^{[3
]}

Yeung, Jensen ^{[3
,4
,5
,6
]}

机构：

[1] Western Univ, Schulich Sch Med & Dent, London, ON, Canada

[2] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada

[3] Univ Toronto, Fac Med, Toronto, ON, Canada

[4] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada

[5] Womens Coll Hosp, Toronto, ON, Canada

[6] Prob Med Res Inc, Waterloo, ON, Canada

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2018年 / 79卷 / 01期

关键词：

D O I：

10.1016/j.jaad.2018.01.003

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：155 / 157

页数：4

共 5 条

[1] Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis [J].

Gordon, K. B. ;

Blauvelt, A. ;

Papp, K. A. ;

Langley, R. G. ;

Luger, T. ;

Ohtsuki, M. ;

Reich, K. ;

Amato, D. ;

Ball, S. G. ;

Braun, D. K. ;

Cameron, G. S. ;

Erickson, J. ;

Konrad, R. J. ;

Muram, T. M. ;

Nickoloff, B. J. ;

Osuntokun, O. O. ;

Secrest, R. J. ;

Zhao, F. ;

Mallbris, L. ;

Leonardi, C. L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (04) :345-356

[2] Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials [J].

Griffiths, Christopher E. M. ;

Reich, Kristian ;

Lebwohl, Mark ;

van de Kerkhof, Peter ;

Paul, Carle ;

Menter, Alan ;

Cameron, Gregory S. ;

Erickson, Janelle ;

Zhang, Lu ;

Secrest, Roberta J. ;

Ball, Susan ;

Braun, Daniel K. ;

Osuntokun, Olawale O. ;

Heffernan, Michael P. ;

Nickoloff, Brian J. ;

Papp, Kim .

LANCET, 2015, 386 (9993) :541-551

[3] Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE [J].

Ortonne, J. -P. ;

Chimenti, S. ;

Reich, K. ;

Gniadecki, R. ;

Sprogel, P. ;

Unnebrink, K. ;

Kupper, H. ;

Goldblum, O. ;

Thaci, D. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (09) :1012-1020

[4] Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: Results from the Italian Psocare Registry [J].

Piaserico, Stefano ;

Cazzaniga, Simone ;

Chimenti, Sergio ;

Giannetti, Alberto ;

Maccarone, Mara ;

Picardo, Mauro ;

Peserico, Andrea ;

Naldi, Luigi .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (02) :257-+

[5] Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept [J].

van Lumig, P. P. M. ;

Lecluse, L. L. A. ;

Driessen, R. J. B. ;

Spuls, P. I. ;

Boezeman, J. B. ;

van de Kerkhof, P. C. M. ;

de Jong, E. M. G. J. .

BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (04) :838-846

← 1 →